Filter
6738
Filtered Results: 6738
Text search:
access
medicines
Featured
Recommendations
586
New Publications
1737
Language
Document type
No document type
3722
Studies & Reports
1315
Guidelines
780
Manuals
346
Strategic & Response Plan
239
Fact sheets
115
Training Material
99
Situation Updates
69
Resource Platforms
22
Infographics
13
Brochures
9
Online Courses
7
App
1
Videos
1
Countries / Regions
India
289
Global
260
Kenya
210
South Africa
171
Ethiopia
152
Uganda
141
Nepal
129
Nigeria
124
Western and Central Europe
124
Sierra Leone
123
Liberia
114
Africa
111
Tanzania
103
Malawi
103
Latin America and the Carribbean
102
Bangladesh
97
Zambia
92
Ukraine
91
Myanmar / Burma
90
Syria
83
Rwanda
80
Ghana
79
Congo, Democratic Republic of
59
Philippines
54
Zimbabwe
53
Eastern Europe
50
Namibia
48
South–East Asia Region
47
Mozambique
45
Venezuela
42
Asia
41
Lesotho
37
East and Southern Africa
37
West and Central Africa
37
Brazil
36
Senegal
34
Cambodia
34
Haiti
33
South Sudan
32
Yemen
32
Guinea
30
Russia
30
Middle East and North Africa
28
Cameroon
26
Germany
26
Indonesia
26
Burkina Faso
24
Botswana
24
Colombia
23
Benin
19
Eswatini/ Swaziland
19
Pakistan
18
Afghanistan
18
Eastern Europe and Central Asia
17
Thailand
16
Sudan
16
USA
14
Lebanon
14
Vietnam
14
Somalia
13
Western Pacific Region
13
Moldova
13
Jordan
12
Tajikistan
12
Mali
11
Peru
11
Sri Lanka
11
China
10
Central African Republic
10
Georgia
10
Albania
9
Southern Africa
9
North America
9
Iraq
8
North Macedonia
8
Bolivia
8
Madagascar
8
Mexico
8
Laos
8
Palestine
7
Turkey
6
Ecuador
6
Chile
6
Poland
6
Côte d’Ivoire / Ivory Coast
5
Egypt
5
Paraguay
5
Iran
5
Kyrgyzstan
5
Kazakhstan
5
Jamaica
5
United Kingdom
5
Saudi Arabia
4
Papua New Guinea
4
Argentina
4
Hungary
4
Burundi
4
El Salvador
4
Libya
4
Canada
4
Romania
4
Turkmenistan
4
Niger
3
Togo
3
Chad
3
Gambia
3
Serbia
3
Greece
3
Angola
3
Guatemala
3
Armenia
3
Timor Leste/ East Timor
3
Uzbekistan
3
Portugal
3
Spain
3
Belarus
3
Guinea-Bissau
2
Morocco
2
Malaysia
2
Switzerland
2
Nicaragua
2
Other region
2
Bhutan
2
Qatar
2
Bulgaria
2
Estonia
2
Lithuania
2
Japan
2
France
2
Mauritius
2
Bosnia and Herzegovina
2
Mauritania
1
Singapore
1
Austria
1
Honduras
1
Fiji
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Slovakia
1
Australia
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2527
Clinical Guidelines
540
Public Health
407
Women & Child Health
309
Key Resources
211
Capacity Building
119
Pharmacy & Technologies
74
Annual Report MEDBOX
3
General Guidelines
1
Protection & Security
1
Toolboxes
HIV
611
COVID-19
528
Mental Health
521
TB
387
AMR
272
Disability
212
Caregiver
204
Planetary Health
200
Conflict
184
Pharmacy
173
NCDs
169
Ebola
168
NTDs
167
Rapid Response
144
Global Health Education
116
Refugee
112
Natural Hazards
68
Health Financing Toolbox
60
Zika
36
Social Ethics
29
Specific Hazards
26
Cholera
25
Polio
16
Typhoon
1
Health Financing
1
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of ...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe)...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national he...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic ...
Pharmadex is a web-based tool that helps streamline and track medicines registration for a national drug regulatory authority. This tool was created by the USAID-funded Systems for Improved Access t...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical .... Through the Global Action Plan on AMR, WHO is working to improve the surveillance of antimicrobial resistance and reduce inappropriate antibiotic consumption.
There is a recognized need for high-quality resources to improve antibiotic prescribing globally. To address this need, a pragmatic approach was taken by WHO to develop actionable guidance for empiric antibiotic use.
The WHO AWaRe (Access, Watch, Reserve) antibiotic book provides concise, evidence-based guidance on the choice of antibiotic, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults in both primary health care and hospital settings. The information included in the book supports the recommendations for antibiotics listed on the WHO Model Lists of Essential Medicines and Essential Medicines Children and the WHO AWaRe classification of antibiotics.
The WHO AWaRe antibiotic book is accompanied by summary infographics for each infection for both adults and children that provide a quick-reference guide for health care workers at the point of care.
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but ... remains lim-
ited. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3.2 million children with SAM have ... to treatment each year2. Thus, there
is a need to scale up interventions to improve coverage and access across high burden countries. While efforts
are currently underway to expand services in many countries, obstacles remain.
One critical barrier to expanding SAM treatment services is the acceptance, accessibility and utilisation of
ready-to-use therapeutic food (RUTF). In some countries and contexts, RUTF is still not fully accepted by
community members; while other countries face problems with procurement, storage and supply chain
management which impact on availability and use3. Reports from Ghana and Zambia highlighted that stock-
outs and logistical challenges are often noted as key contributors to high default rates in outpatient treatment
centres4.
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see pro...
The shortage of human resources for health, and in particular physicians, is one of the major barriers to achieve universal access to HIV care and treatment. In September 2005, a pilot program of nurse-centered antiretroviral treatment (ART) prescri...
In 2018, approximately 60,000 Ugandans were estimated to be suffering from cancer. It was also reported that only 5% of cancer patients access cancer care and 77% present with late-stage cancer coupled with low level of cancer health literacy in the...
The Emergency Access Initiative (EAI) has been activated in support of medical efforts related to the Ebola Outbreak in West Africa. The Emergency Access Initiative is a col-
laborative partnership...
The article examines the epidemiology of chronic obstructive pulmonary disease (COPD) in the Middle East, North Africa, and Turkey. It provides an overview of COPD prevalence, associated risk factors, and challenges in diagnosis and treatment across these regions. The study highlights smoking and en...
Original Research
African Journal of Primary Health Care & Family Medicine
ISSN: (Online) 2071-2936, (Print) 2071-2928
Open Access
Senegal has adopted the World Health Organization–Joint United Nations Programme on HIV/AIDS recommended 90-90-90 targets.5 The adoption of this strategy means that the country is expected, by 2020, to have 90% of its population living with HIV diagnosed, 90% of all those diagnosed receiving susta...
With the growing prevalence of type 2 diabetes, particularly in emerging countries, its management in the context of available resources should be considered. International guidelines, while comprehensive and scientifically valid, may not be appropriate for regions such as Asia, Latin America or Afr...
The United Nations Population Fund (UNFPA) is the lead UN agency working to further gender equality and women’s empowerment in Sri Lanka. We are pleased to be a part of the joint effort with the Ministry of Health to develop the first ‘Standard Operating Procedures on sexual and gender-based vio...
The Knowledge Translation Unit is a group within the University of Cape Town’s Lung Institute and Department of Medicine who has worked on primary care programmes to strengthen provision of evidence-informed care in low-resources settings in South...
